IL-6 Protects Against T Cell-Mediated Liver Injury in Mice
Author Information
Author(s): Cheng Liang, Wang Jun, Li Xiaozhu, Xing Qiao, Du Peishuang, Su Lishan, Wang Shengdian
Primary Institution: Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
Hypothesis
What is the role of IL-6 in protecting against CD8+ T cell-mediated liver injury?
Conclusion
IL-6 induces Gr-1+CD11b+ myeloid cells in the liver to inhibit T cell-mediated liver injury.
Supporting Evidence
- IL-6 treatment led to increased infiltration of immune cells in the liver without causing liver injury.
- Mice treated with IL-6 showed reduced proliferation of CD8+ T cells.
- Gr-1+CD11b+ myeloid cells induced by IL-6 were found to inhibit T cell activation.
Takeaway
This study found that a substance called IL-6 helps protect the liver from damage caused by certain immune cells in mice.
Methodology
Mice were treated with IL-6 and a CD137 agonistic antibody, and various immune responses and liver injuries were measured.
Limitations
The study was conducted in mice, which may not fully replicate human responses.
Participant Demographics
Female C57BL/6 mice, aged 6–8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website